Posted by linkadge on June 3, 2008, at 10:14:37
In reply to Re: Mirapex vs. Seroquel for SSRI-induced anhedoni » bleauberry, posted by satsumas on May 31, 2008, at 20:33:38
As an atypical, zyprexa will block 5-ht2a/c receptors a little more strongly than dopamine receptors. It will antagonize dopamine receptors at any dose however. At lower doses this may or may not be prominent. Most people augment with as little as 2.5mg but many people still notice dopamine related
side effects at this dose.Metabolically, Zyprexa is bad news though. Lilly just paid a huge settlement for downplaying these side effects and pushing the drug for non-approved uses. The drug is diabetogenic. Even in the absence of significant weight gain it can still damage pancreatic cells which can lead to more problems long term.
Linkadge
poster:linkadge
thread:832091
URL: http://www.dr-bob.org/babble/20080528/msgs/832667.html